Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis

Mohammed D. SaleemDepartment of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA; Correspondence[email protected]
View further author information

Steven R. FeldmanDepartment of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA; ;Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA; ;Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information

References

Huang KE, Davis SA, Cantrell J, Feldman SR. Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions. Dermatol Online J. 2014;20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25244174
Google Scholar
Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008;59:448–55.
PubMed Web of Science ®Google Scholar
FDA. CLOBEX spray full prescribing information. NDA 021835/S-006. October, 2012.
Google Scholar
Review Letter IND 101789 Desoximetasone Spray, 0.25%. Center for Drug Evaluation and Research, Division of Dermatology and Dental Products July, 2009.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date